Ascent Capital tastes a lemon in exit from healthcare firm

By Ankit Doshi

  • 13 May 2020
Premium
Credit: VCCircle

Ascent Capital will fully exit a publicly listed animal healthcare company with token gains via a buyout deal, in yet another instance of the homegrown private equity firm recording a below-par performance. Last week, private equity firm Carlyle agreed to acquire up to 74% of Bengaluru-based pharmaceutical company SeQuent Scientific Ltd ......

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Already a member? Click here to log in.